Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma
Sandra P. D’Angelo, Matthias Hunger, Andrew S. Brohl, Paul Nghiem, Shailender Bhatia, Omid Hamid, Janice M. Mehnert, Patrick Terheyden, Kent C. Shih, Isaac Brownell, Céleste Lebbé, Karl D. Lewis, Gerald P. Linette, Michele Milella, Michael Schlichting, Meliessa H. Hennessy, Murtuza Bharmal
Dive into the research topics of 'Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma'. Together they form a unique fingerprint.